Evaluation of a Trabecular Micro-Bypass Stent in Pseudophakic Patients With Open-Angle Glaucoma.
Ferguson Tanner J, Berdahl John P, Schweitzer Justin A, Sudhagoni Ramu
AI Summary
This study found iStent effectively lowered IOP in pseudophakic open-angle glaucoma patients over two years, with favorable safety. Medication use wasn't significantly reduced, but most patients maintained or decreased medications.
Abstract
Purpose of the study: The purpose of the study was to evaluate the safety and efficacy of the iStent Trabecular Micro-Bypass stent in pseudophakic patients with open-angle glaucoma.
Methods
Retrospective, consecutive case series from October 2012 to May 2015 with no exclusion criteria. The series comprised 42 pseudophakic eyes with open-angle glaucoma that were implanted with 1 iStent. Data were collected preoperatively, and postoperative data were collected at 1 day, 1 week, 1, 3 and 6 months, 1 year, 18 months and 2 years. Data included intraocular pressure (IOP), number of glaucoma medications, the incidence of postoperative IOP pressure spikes ≥15 mm Hg at any timepoint, and the need for additional surgery.
Results
The mean preoperative IOP was 20.26±6.00 mm Hg. At 1 year postoperatively, the mean IOP was 16.34±3.78 mm Hg (P<0.01). At 2 years postoperatively, the mean IOP was 13.62±4.55 (P<0.01). The mean number of glaucoma medications was 1.95±1.01 preoperative and 1.69±1.28 (P>0.05) at 1 year postoperatively. Postoperatively, 3 eyes (7%) experienced an IOP increase of 15 mm Hg above their baseline IOP that responded to topical therapy. In total, 96% of patients with an IOP≥19 mm Hg achieved a reduction in IOP at their last collected follow-up.
Conclusions
The insertion of the iStent Trabecular Micro-Bypass stent effectively lowers IOP in pseudophakic patients with open-angle glaucoma. Although medication use was not significantly reduced postoperatively at 1 year, 80% of patients either experienced a reduction or no change in medication use. The safety profile appears favorable with a low rate of IOP spikes and only 1 patient requiring additional surgery.
MeSH Terms
Shields Classification
Key Concepts6
At 1 year postoperatively, the mean IOP in pseudophakic patients with open-angle glaucoma who were implanted with one iStent Trabecular Micro-Bypass stent was 16.34±3.78 mm Hg (P<0.01).
At 2 years postoperatively, the mean IOP in pseudophakic patients with open-angle glaucoma who were implanted with one iStent Trabecular Micro-Bypass stent was 13.62±4.55 mm Hg (P<0.01).
The mean number of glaucoma medications for pseudophakic patients with open-angle glaucoma who were implanted with one iStent Trabecular Micro-Bypass stent was 1.95±1.01 preoperatively and 1.69±1.28 (P>0.05) at 1 year postoperatively.
Postoperatively, 3 eyes (7%) of pseudophakic patients with open-angle glaucoma implanted with one iStent Trabecular Micro-Bypass stent experienced an IOP increase of 15 mm Hg above their baseline IOP that responded to topical therapy.
96% of pseudophakic patients with open-angle glaucoma who had an IOP≥19 mm Hg and were implanted with one iStent Trabecular Micro-Bypass stent achieved a reduction in IOP at their last collected follow-up.
The mean preoperative IOP in pseudophakic patients with open-angle glaucoma who were implanted with one iStent Trabecular Micro-Bypass stent was 20.26±6.00 mm Hg.
Related Articles5
Two-Year Outcomes of Phacogoniotomy vs Phacotrabeculectomy for Advanced Primary Angle-Closure Glaucoma With Cataract: A Noninferiority Randomized Clinical Trial.
Randomized Controlled TrialPattern of Long-Term Intraocular Pressure Variation Following Gonioscopy-Assisted Transluminal Trabeculotomy: Two-Year Outcomes.
Cohort StudyAnterior Chamber Angle and Intraocular Pressure Control After Phacoemulsification in Primary Angle Closure With Different Mechanisms.
Cohort StudyCataract surgery and intraocular pressure in glaucoma.
ReviewThe Hydrus Microstent in Pseudophakic Patients With Medically Refractory Open-angle Glaucoma.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.